The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...
Zacks.com on MSN23h
Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales ViewThis week Novartis NVS upgraded its mid-term sales growth guidance. The European Commission approved Pfizer’s PFE hemophilia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback